Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam

References

• Bich, N. N., de Vries, P. J., Van, T. H., Phong, T. H., Hung, L. N., Eggelte, T. A., Anh, T. K. & Kager, P. A. (1996). Efficacy and tolerance of artemisinin in short combination regimens for the treatment of uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, 55, 438–443.
   PubMed Web of Science ®Google Scholar
• Bustos, D. G., Canfield, C. J., Editha, C. M. & Hutchinson, D. B. (1999). Atovaquone—proguanil com-pared with chlomquine and chlomquine—sulfadoxine—pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. Journal of Infectious Diseases, 179, 1587–1590.
   PubMed Web of Science ®Google Scholar
• Charoenteeraboon, J., Kamchonwongpaisan, S., Wilairat, P., Vattanaviboon, P. & Yuthavong, Y. (2000). Inactivation of artemisinin by thalassemic erythrocytes. Biochemical Pharmacology, 59, 1337–1344.
   PubMed Web of Science ®Google Scholar
• Denis, M. B., Davis, T. M., Hewitt, S., Incardona, S., Nimol, K., Fandeur, T., Poravuth, Y., Lim, C. & Socheat, D. (2002). Efficacy and safety of dihydro-artemisinin—piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clinical Infectious Diseases, 35, 1469–1476.
   PubMed Web of Science ®Google Scholar
• Fivelman, Q. L., Butcher, G. A., Adagu, I. S., Warhurst, D. C. & Pasvol, G. (2002). Malarone treat-ment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malaria Journal, 1, 1.
   PubMedGoogle Scholar
• Giao, P. T., Binh, T. Q., Kager, P. A., Long, H. P., Van Thang, N., Van Nam, N. & de Vries, P. J. (2001). Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? American Journal of Tropical Medicine and Hygiene, 65, 690–695.
   PubMed Web of Science ®Google Scholar
• Hudson, A. T., Dickins, M., Ginger, C. D., Gutteridge, W. E., Holdich, T., Hutchison, D. B. A., Pudney, M., Randall, A. W. & Latter, V. S. (1991). 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Under Experimental and Clinical Research, 17,427–435.
   PubMedGoogle Scholar
• Hung, L. Q., de Vries, P. J., Giao, P. T., Nam, N. V., Binh, T. Q., Chong, M. T., Quoc, N. T. T. A., Thanh, T. N., Hung, L. N. & Kager, P. A. (2002). Malaria control: a successful experience in South Vietnam. Bulletin of the World Health Organization, 80, 660–666.
   PubMed Web of Science ®Google Scholar
• Le, H. N., de Vries, P. J., Le, T. D., Bich, L. N., Ho, P. L., Tran, N. H., Nguyen, N. V., Trinh, K. A. & Kager, P. A.(1997). Single dose artemisinin-mefloquine versus mefloquine alone for uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 191–194.
   Google Scholar
• Looareesuwan, S., Viravan, C., Webster, H. K., Dennis, E. K., Hutchinson, D. B. & Canfield, C. J. (1996). Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treat-ment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 54,62–66.
   PubMed Web of Science ®Google Scholar
• Looareesuwan, S., Chulay, J. D., Canfield, C. J. & Hutchinson, D. B. (1999a). Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. American Journal of Tropical Medicine and Hygiene, 60, 533–541.
   PubMed Web of Science ®Google Scholar
• Looareesuwan, S., Wilairatana, P., Chalermarut, K., Rattanapaong, Y., Canfield, C. J. & Hutchinson, D. B. (1999 b). Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 60, 526–532.
   PubMed Web of Science ®Google Scholar
• Luxemburger, C., Brockman, A., Silamut, K., Nosten, F., van Vugt, M., Gimenez, F., Chongsuphajaisiddhi, T. & White, N. J. (1998). Two patients with falciparum malaria and poor in vivo responses to artesunate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 668–669.
   PubMed Web of Science ®Google Scholar
• Radloff, P. D., Philipps, J., Nkeyi, M., Hutchinson, D. & Kremsner, P. G. (1996). Atovaquone and pro-guanil for Plasmodium falciparum malaria. Lancet, 347, 1511–1514.
   PubMed Web of Science ®Google Scholar
• Schuftan, C. & Cong, L. D. (2001). The successful fight against malaria in Vietnam. Mekong Malaria Forum, 8, 30–35.
   Google Scholar
• Srivastava, I. K. & Vaidya, A. B. (1999). A mechanism for the synergistic antimalaria action of atovaquone and proguanil. Antimicrobial Agents and Chemotherapy, 43, 1334–1339.
   PubMed Web of Science ®Google Scholar
• Thanh, N. V., Cowman, A. F., Hipgrave, D., Kim, T. B., Phuc, B. Q., Cong, L. D. & Biggs, B. A. (2001). Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, meflo-quine, sulfadoxine-pyrimethamine and artemisinin in southern Vietnam. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 513–517.
   PubMed Web of Science ®Google Scholar
• Trung, T. N., Davis, T. M., Hewitt, S., Thuan, L. K., Quang, H. H., Anh, C. V., Thuy, P. T., Thoa, N. T., Tuan, N. T., Hang, N. T. & Giang, L. T. (2001). Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens. Annals of Tropical Paediatrics, 21, 307–312.
   PubMed Web of Science ®Google Scholar
• Van Vugt, M., Leonardi, E., Phaipun, L., Slight, T., Thway, K. L., McGready, R., Brockman, A., Villegas, L., Looareesuwan, S., White, N. J. & Nosten, F. (2002). Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clinical Infectious Diseases, 35, 1498–1504.
   Google Scholar
• White, N. J. (1999). Antimalarial drug resistance and combination chemotherapy. Philosophical Trans-actions of the Royal Society of London, Series B, 354, 739–749.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1998). The Use of Artenzisinin and its Derivatives as Anti-malarial Drugs. Report of a Joint CTDIDMPITDR Informal Consultation. Document WHO/MAL/98. 1086. Geneva: WHO.
   Google Scholar
• World Health Organization (2002). Report Meeting on Antimalarial Drug Development, Shanghai, China, 16-17 November 2001, Manila, Philippines. Document RS/2001/GE/33(CHN). Geneva: WHO.
   Google Scholar
• Yuthavong, Y., Butthep, P., Bunyaratvej, A. & Fucharoen, S. (1989). Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes. Journal of Clinical Investigation, 83, 502–505.
   PubMed Web of Science ®Google Scholar